ATE24904T1 - Verbindungen wirksam in der behandlung von magengeschwueren und von hautueberempfindlichkeitssymptomen. - Google Patents

Verbindungen wirksam in der behandlung von magengeschwueren und von hautueberempfindlichkeitssymptomen.

Info

Publication number
ATE24904T1
ATE24904T1 AT83100992T AT83100992T ATE24904T1 AT E24904 T1 ATE24904 T1 AT E24904T1 AT 83100992 T AT83100992 T AT 83100992T AT 83100992 T AT83100992 T AT 83100992T AT E24904 T1 ATE24904 T1 AT E24904T1
Authority
AT
Austria
Prior art keywords
amine
treatment
cyclohexadienyl
compounds effective
skin sensitivity
Prior art date
Application number
AT83100992T
Other languages
German (de)
English (en)
Inventor
Adolfo Moroni
Original Assignee
Magis Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magis Farmaceutici filed Critical Magis Farmaceutici
Application granted granted Critical
Publication of ATE24904T1 publication Critical patent/ATE24904T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/12Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT83100992T 1982-04-27 1983-02-03 Verbindungen wirksam in der behandlung von magengeschwueren und von hautueberempfindlichkeitssymptomen. ATE24904T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20954/82A IT1190793B (it) 1982-04-27 1982-04-27 Composti attivi nel trattamento dell'ulcera e sintomi allergici della pelle
EP83100992A EP0092647B1 (en) 1982-04-27 1983-02-03 New active compounds in the treatment of ulcers and skin allergy symptoms

Publications (1)

Publication Number Publication Date
ATE24904T1 true ATE24904T1 (de) 1987-01-15

Family

ID=11174566

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83100992T ATE24904T1 (de) 1982-04-27 1983-02-03 Verbindungen wirksam in der behandlung von magengeschwueren und von hautueberempfindlichkeitssymptomen.

Country Status (8)

Country Link
US (1) US4613596A (en, 2012)
EP (1) EP0092647B1 (en, 2012)
JP (1) JPS6081177A (en, 2012)
AT (1) ATE24904T1 (en, 2012)
AU (1) AU563738B2 (en, 2012)
CA (1) CA1223257A (en, 2012)
DE (1) DE3369135D1 (en, 2012)
IT (1) IT1190793B (en, 2012)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196133B (it) * 1984-06-06 1988-11-10 Ausonia Farma Srl Derivati furanici con attivita' antiulcera
IT1180185B (it) * 1984-06-12 1987-09-23 Magis Farmaceutici Derivato della ranitidina utile nel trattamento dell'ulcera
US4707550A (en) * 1986-04-28 1987-11-17 Ortho Pharmaceutical Corporation N-(substituted thienyl)-N'-(substituted piperazinyl)-ureas
IL100688A (en) * 1987-08-01 1995-08-31 Takeda Chemical Industries Ltd Intermediates for the production of unsaturated amines in position A and the process for their preparation
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
CA2189964A1 (en) * 1994-05-18 1995-11-23 Haruhiko Kikuchi Novel diaminomethylidene derivative
US6248785B1 (en) 1996-08-06 2001-06-19 Smithkline Beecham Corporation IL-8 receptor antagonists
US6177448B1 (en) 1996-08-06 2001-01-23 Smithkline Beecham Corporation IL-8 receptor antagonists
EP1116486A4 (en) * 1998-09-22 2007-06-20 Ishihara Sangyo Kaisha MEDICAL COMPOSITION CONTAINING NITROETHENAMINE DERIVATIVES OR SALTS AS ACTIVE INGREDIENTS
KR20080035702A (ko) 2002-01-11 2008-04-23 상꾜 가부시키가이샤 아미노 알코올 유도체 또는 포스폰산 유도체 및 이들을함유하는 의약 조성물
CN1921847B (zh) 2004-02-24 2010-06-16 三共株式会社 氨基醇化合物
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4287346A (en) * 1979-02-16 1981-09-01 Eisai Co., Ltd. Cyanoguanidine derivatives
EP0057981A3 (en) * 1981-02-09 1982-08-25 Beecham Group Plc Aromatic compounds, processes for their preparation and their use

Also Published As

Publication number Publication date
IT8220954A0 (it) 1982-04-27
EP0092647A1 (en) 1983-11-02
JPH0429671B2 (en, 2012) 1992-05-19
AU563738B2 (en) 1987-07-23
IT1190793B (it) 1988-02-24
AU1976083A (en) 1985-04-04
JPS6081177A (ja) 1985-05-09
DE3369135D1 (en) 1987-02-19
EP0092647B1 (en) 1987-01-14
CA1223257A (en) 1987-06-23
US4613596A (en) 1986-09-23

Similar Documents

Publication Publication Date Title
FI96690B (fi) Menetelmä valmistaa terapeuttisesti aktiivista bentsopyridopiperidiini-, piperidylideeni- ja -piperatsiiniyhdistettä
ATE24904T1 (de) Verbindungen wirksam in der behandlung von magengeschwueren und von hautueberempfindlichkeitssymptomen.
SE8203051L (sv) 1-(aminoalkyl)-2-aryl-cyklohexanalkoholer och -estrar
NZ314207A (en) 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
NO174049C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-lipoksygenase-inhiberende 4-(4-fenyl-1-piperazinyl)fenoler
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
NO904839L (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
ATE88894T1 (de) Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen.
ES8801187A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
UY23624A1 (es) Procedimiento para la preparacion de nuevos derivados de indol
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
ATE2265T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
UA41928C2 (uk) Похідні оксазолідину, спосіб їх одержання, фармацевтична композиція та спосіб її одержання, спосіб лікування захворювань
ES482472A1 (es) Procedimiento para la preparacion de isoquinoleinas.
ES8406070A1 (es) Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica
NO913391L (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
ES419814A1 (es) Un procedimiento de preparacion de un nuevo derivado amini-co del 1,4-benzodioxano.
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
ATE74138T1 (de) Heptanoyl-glu-asp-ala-amino-saeureimmunstimulanten.
ZA859706B (en) Organic compounds and their pharmaceutical use
NO170274C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme benzhydryloksyetylpiperidin-derivater
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IL42944A (en) Basically substituted benzene-1,3-disulfonamides and process for their manufacture
GB1449802A (en) Piperazine derivatives and compositions containing them for treating parkinsons disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee